133 related articles for article (PubMed ID: 8009259)
1. Treatment of Paget's disease of bone with single-dose intravenous pamidronate.
Watts RA; Skingle S; Bhambani M; Pountain G; Crisp AJ
Semin Arthritis Rheum; 1994 Feb; 23(4):281. PubMed ID: 8009259
[No Abstract] [Full Text] [Related]
2. Moderate Paget's disease treated with pamidronate: comparison of various infusion rates for a 60-mg single dose.
Thiebaud D; Portmann L; Burckhardt P
Semin Arthritis Rheum; 1994 Feb; 23(4):279. PubMed ID: 8009257
[No Abstract] [Full Text] [Related]
3. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ
Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
Grauer A; Klar B; Scharla SH; Zieglar R
Semin Arthritis Rheum; 1994 Feb; 23(4):283-4. PubMed ID: 8009261
[No Abstract] [Full Text] [Related]
5. Treatment of Paget's disease of bone.
Anderson D; Cantrill JC
Br Med J (Clin Res Ed); 1988 Jan; 296(6617):291. PubMed ID: 3124919
[No Abstract] [Full Text] [Related]
6. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
Fritz P; Lioté F; Kuntz D
Semin Arthritis Rheum; 1994 Feb; 23(4):282. PubMed ID: 8009260
[No Abstract] [Full Text] [Related]
7. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
Stuckey BG; Gutteridge DH; Stewart GO; Prince RL; Ward LC; Kent GN; Prince RI; Retallack RW; Bhagat CI; Nicholson GC
Semin Arthritis Rheum; 1994 Feb; 23(4):286. PubMed ID: 8009263
[No Abstract] [Full Text] [Related]
8. Effects of intravenous pamidronate therapy on Paget's disease of bone.
Bombassei GJ; Yocono M; Raisz LG
Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
[TBL] [Abstract][Full Text] [Related]
9. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Wimalawansa SJ; Gunasekera RD
Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
Stone MD; Hawthorne AB; Kerr D; Webster G; Hosking DJ
J Bone Miner Res; 1990 Dec; 5(12):1231-5. PubMed ID: 2075835
[TBL] [Abstract][Full Text] [Related]
11. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
Montagnani A; Gonnelli S; Cepollaro C; Campagna MS; Franci MB; Pacini S; Gennari C
Bone; 2003 Jan; 32(1):15-9. PubMed ID: 12584031
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous aminopropylidene bisphosphonate in patients with refractory Paget's disease.
Cormier C; Hilliquin P; Menkès CJ
Br J Rheumatol; 1993 Aug; 32(8):767-8. PubMed ID: 8348290
[No Abstract] [Full Text] [Related]
13. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
Gutteridge DH; Retallack RW; Ward LC; Stuckey BG; Stewart GO; Prince RL; Kent GN; Bhagat CI; Price RI; Thompson RI; Nicholson GC
Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145
[TBL] [Abstract][Full Text] [Related]
14. Single-day intravenous pamidronate in Paget's disease.
Hooper MJ; Clifton-Bligh P; Marel GM; Lang FV; Tancred J; McDowall D; Forman L
Semin Arthritis Rheum; 1994 Feb; 23(4):276-7. PubMed ID: 8009255
[TBL] [Abstract][Full Text] [Related]
15. Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.
Stewart GO; Gutteridge DH; Price RI; Ward L; Retallack RW; Prince RL; Stuckey BG; Kent GN; Bhagat CI; Dhaliwal SS
Bone; 1999 Feb; 24(2):139-44. PubMed ID: 9951784
[TBL] [Abstract][Full Text] [Related]
16. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
Ryan PJ; Gibson T; Fogelman I
J Nucl Med; 1992 Sep; 33(9):1589-93. PubMed ID: 1517830
[TBL] [Abstract][Full Text] [Related]
17. Single-dose intravenous pamidronate is effective alternative therapy for Paget's disease refractory to calcitonin.
Yap AS; Mortimer RH; Jacobi JM; Galligan JP; Perry-Keene DA; Khafagi FA
Horm Res; 1991; 36(1-2):70-4. PubMed ID: 1814803
[TBL] [Abstract][Full Text] [Related]
18. Ototoxicity associated with intravenous bisphosphonate administration.
Reid IR; Mills DA; Wattie DJ
Calcif Tissue Int; 1995 Jun; 56(6):584-5. PubMed ID: 7648491
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
Scharla SH; Grauer A; Ziegler R
Klin Wochenschr; 1991 Jan; 69(1):25-30. PubMed ID: 2016845
[TBL] [Abstract][Full Text] [Related]
20. Effect of pamidronate on indices of bone turnover in Paget's disease followed for 6 years.
Worsfold M; Sharp CA; Rowlands PR; Davie MW
Semin Arthritis Rheum; 1994 Feb; 23(4):285. PubMed ID: 8009262
[No Abstract] [Full Text] [Related]
[Next] [New Search]
